Rainer Blair Biography and Net Worth

Rainer Blair is the President and Chief Executive Officer of Danaher Corporation. Beginning September 2020, Rainer has led Danaher’s $22B global, multi-industry portfolio of businesses. With the help of Danaher’s 69,000 global associates, he is focused on further strengthening Danaher’s position as a leading science and technology company.

Rainer is a dedicated leader and practitioner of the Danaher Business System, the company’s pre-eminent operating model and cultural foundation. He is deeply committed to the company’s Core Values and Shared Purpose: Helping Realize Life’s Potential. He has been a principle architect of Danaher’s associate engagement strategy and Diversity + Inclusion journey.

Rainer brings more than 30 years of deep and diverse experience to his current role. Rainer joined Danaher in 2010 and held leadership roles across several operating companies before being named Executive Vice President of Danaher’s Life Sciences platform in 2014. Through a combination of organic and inorganic growth investments, he helped Danaher build a portfolio of Life Sciences businesses uniquely positioned to reduce time to market and cost of biologic drugs. Under his leadership, the Life Sciences platform annual revenues increased five-fold to approximately $10 billion today.

Prior to Danaher, Rainer was President and CEO for MAPEI Americas, a $2.3 billion global, diversified construction chemical corporation. He previously spent 15 years with BASF Group on three continents with progressively larger leadership roles. He is U.S. Army veteran. He earned his B.A. from the University of Massachusetts - Amherst and his M.S. from Boston University. Rainer and his wife Alaine live in Alexandria, VA, and have three adult children.

What is Rainer M. Blair's net worth?: The estimated net worth of Rainer M. Blair is at least $19.97 million as of August 15th, 2022. Mr. Blair owns 79,739 shares of Danaher stock worth more than $19,967,443 as of April 24th. This net worth approximation does not reflect any other assets that Mr. Blair may own. Additionally, Mr. Blair receives a salary of $5,330,000.00 as EVP at Danaher. Learn More about Rainer M. Blair's net worth.
How old is Rainer M. Blair?: Mr. Blair is currently 60 years old. There are 7 older executives and no younger executives at Danaher. Learn More on Rainer M. Blair's age.
What is Rainer M. Blair's salary?: As the EVP of Danaher Co., Mr. Blair earns $5,330,000.00 per year. Learn More on Rainer M. Blair's salary.
How do I contact Rainer M. Blair?: The corporate mailing address for Mr. Blair and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Rainer M. Blair's contact information.
Has Rainer M. Blair been buying or selling shares of Danaher?: Rainer M. Blair has not been actively trading shares of Danaher during the last quarter. Most recently, Rainer Blair sold 25,000 shares of the business's stock in a transaction on Monday, August 15th. The shares were sold at an average price of $300.00, for a transaction totalling $7,500,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,739 shares of the company's stock, valued at $23,921,700. Learn More on Rainer M. Blair's trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 14 times. They sold a total of 115,345 shares worth more than $28,921,815.03. The most recent insider tranaction occured on February, 26th when SVP Daniel Raskas sold 23,757 shares worth more than $5,986,764.00. Insiders at Danaher own 10.9% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 2/26/2024.

Rainer M. Blair Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2022	Sell	25,000	$300.00	$7,500,000.00	79,739
5/28/2020	Sell	3,330	$165.96	$552,646.80	36,256
2/27/2019	Sell	37,859	$127.45	$4,825,129.55	32,661
2/26/2018	Sell	3,981	$100.05	$398,299.05	49,751
2/21/2018	Sell	51,080	$97.26	$4,968,040.80	50,477

Rainer M. Blair Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $250.41

$247.98

$254.09

50 Day Range

MA: $248.95

$235.37

$256.19

2 Week Range

Now: $250.41

$182.09

$259.00

Volume

3,270,122 shs

Average Volume

2,783,958 shs

Market Capitalization

$185.44 billion

P/E Ratio

39.19

Dividend Yield

0.46%

Beta

0.83

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

Rainer Blair Biography and Net Worth

What is Rainer M. Blair's net worth?

How old is Rainer M. Blair?

What is Rainer M. Blair's salary?

How do I contact Rainer M. Blair?

Has Rainer M. Blair been buying or selling shares of Danaher?

Who are Danaher's active insiders?

Are insiders buying or selling shares of Danaher?